验证M-CHARTS用于孔源性视网膜脱离修复术后视物变形的定量评估
在加拿大多伦多St. Michael's医院开展的前瞻性观察性研究,纳入50例原发性单侧孔源性视网膜脱离患者和50例健康对照,于3个月时用改良MeMoQ问卷和M-CHARTS评估视物变形。M-CHARTS总分≥0.2时检测视物变形的敏感度为72.7%、特异度为94.6%,曲线下面积为0.801,与MeMoQ评分显著相关。
要点
- 50例RRD患者中70%(35/50)经M-CHARTS检出视物变形,80%(40/50)经MeMoQ报告视物变形。
- M-CHARTS总分≥0.2检测视物变形的敏感度72.7%、特异度94.6%,ROC曲线下面积0.801。
- M-CHARTS水平、垂直及总分均与MeMoQ评分显著相关,r_s分别为0.465、0.405、0.475。
核心结论
- 作者验证了M-CHARTS可作为定量评估孔源性视网膜脱离患者视物变形的工具,其评分与MeMoQ患者报告结局显著相关。
- M-CHARTS总分≥0.2时与MeMoQ的相关性更强(r_s=0.454,P=0.001)。
研究设计与样本
- 前瞻性观察性研究,经研究伦理委员会批准,在加拿大多伦多St. Michael's医院开展。
- 纳入原发性单侧孔源性视网膜脱离患者和健康对照,共100例(RRD组50例,对照组50例),于3个月时评估视物变形。
主要发现
- RRD组M-CHARTS检出视物变形者占70%(35/50),MeMoQ报告视物变形者占80%(40/50)。
- RRD组改良MeMoQ评分和M-CHARTS总分均显著高于对照组(P<0.0001)。
- RRD组Cronbach's alpha信度系数为0.934。
- M-CHARTS水平、垂直及总分与MeMoQ评分显著相关(r_s=0.465,P=0.0007;r_s=0.405,P=0.004;r_s=0.475,P=0.0005)。
- M-CHARTS(阳性评分≥0.2)检测视物变形的敏感度为72.7%、特异度为94.6%,ROC曲线下面积为0.801。
关键数值与推荐
- M-CHARTS总分≥0.2视为阳性,检测视物变形的敏感度72.7%、特异度94.6%,ROC曲线下面积0.801。
- 在M-CHARTS评分≥0.2且MeMoQ报告视物变形的患者中,两者相关性更强(r_s=0.454,P=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To validate the quantitative assessment of metamorphopsia in rhegmatogenous retinal detachment (RRD) using M-CHARTS by determining its correlation with subjective reporting of metamorphopsia with a validated metamorphopsia questionnaire (modified MeMoQ). METHODS: The Research Ethics Board approved a prospective observational study carried out at St. Michael's Hospital, Toronto, Canada. Patients with primary, unilateral RRD and healthy controls were included. Metamorphopsia at 3 months was assessed with modified MeMoQ and M-CHARTS. RESULTS: One hundred patients (50 with RRD, 50 controls) were included. Seventy percent (35/50) of the RRD group had metamorphopsia with M-CHARTS and 80% (40/50) with MeMoQ. The modified MeMoQ and total M-CHARTS scores were significantly higher in patients with RRD compared with controls ( P < 0.0001). Cronbach's alpha reliability coefficient was 0.934 in the RRD group. Horizontal, vertical, and total M-CHARTS scores were significantly correlated with MeMoQ scores (r s = 0.465, P = 0.0007; r s = 0.405, P = 0.004; r s = 0.475, P = 0.0005, respectively). M-CHARTS was 72.7% sensitive and 94.6% specific for detection of metamorphopsia (positive score ≥ 0.2), with an area under the receiver operating characteristic curve = 0.801. A stronger correlation was found in patients who scored ≥0.2 on the M-CHARTS and reported metamorphopsia with the MeMoQ (r s = 0.454, P = 0.001). CONCLUSION: The authors have validated M-CHARTS as a tool to quantitatively assess metamorphopsia in patients with RRD, which is significantly correlated with patient-reported outcomes using the MeMoQ. A total score of ≥0.2 with M-CHARTS was more strongly correlated with MeMoQ.
引用
- Oquendo PL, Figueiredo N, Francisconi CLM, et al. VALIDATION OF M-CHARTS FOR QUANTITATIVE ASSESSMENT OF METAMORPHOPSIA FOLLOWING RHEGMATOGENOUS RETINAL DETACHMENT REPAIR. Retina. 2024. PMID: 38354405. doi:10.1097/IAE.0000000000004071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。